807 related articles for article (PubMed ID: 14691214)
1. DNA adduct formation in precision-cut rat liver and lung slices exposed to benzo[a]pyrene.
Harrigan JA; Vezina CM; McGarrigle BP; Ersing N; Box HC; Maccubbin AE; Olson JR
Toxicol Sci; 2004 Feb; 77(2):307-14. PubMed ID: 14691214
[TBL] [Abstract][Full Text] [Related]
2. Tissue specific induction of cytochrome P450 (CYP) 1A1 and 1B1 in rat liver and lung following in vitro (tissue slice) and in vivo exposure to benzo(a)pyrene.
Harrigan JA; McGarrigle BP; Sutter TR; Olson JR
Toxicol In Vitro; 2006 Jun; 20(4):426-38. PubMed ID: 16198082
[TBL] [Abstract][Full Text] [Related]
3. Influence of TCDD and natural Ah receptor agonists on benzo[a]pyrene-DNA adduct formation in the Caco-2 human colon cell line.
de Waard PW; de Kok TM; Maas LM; Peijnenburg AA; Hoogenboom RL; Aarts JM; van Schooten FJ
Mutagenesis; 2008 Jan; 23(1):67-73. PubMed ID: 18065724
[TBL] [Abstract][Full Text] [Related]
4. Benzo[a]pyrene-induced toxicity: paradoxical protection in Cyp1a1(-/-) knockout mice having increased hepatic BaP-DNA adduct levels.
Uno S; Dalton TP; Shertzer HG; Genter MB; Warshawsky D; Talaska G; Nebert DW
Biochem Biophys Res Commun; 2001 Dec; 289(5):1049-56. PubMed ID: 11741297
[TBL] [Abstract][Full Text] [Related]
5. Sustained overexpression of CYP1A1 and 1B1 and steady accumulation of DNA adducts by low-dose, continuous exposure to benzo[a]pyrene by polymeric implants.
Jeyabalan J; Vadhanam MV; Ravoori S; Gupta RC
Chem Res Toxicol; 2011 Nov; 24(11):1937-43. PubMed ID: 21942922
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the precision-cut liver and lung slice systems for the study of induction of CYP1, epoxide hydrolase and glutathione S-transferase activities.
Pushparajah DS; Umachandran M; Plant KE; Plant N; Ioannides C
Toxicology; 2007 Feb; 231(1):68-80. PubMed ID: 17178432
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of chrysoeriol on DNA adduct formation with benzo[a]pyrene in MCF-7 breast cancer cells.
Takemura H; Nagayoshi H; Matsuda T; Sakakibara H; Morita M; Matsui A; Ohura T; Shimoi K
Toxicology; 2010; 274(1-3):42-8. PubMed ID: 20553787
[TBL] [Abstract][Full Text] [Related]
8. Regulation of benzo[a]pyrene-mediated DNA- and glutathione-adduct formation by 2,3,7,8-tetrachlorodibenzo-p-dioxin in human lung cells.
Gelhaus SL; Harvey RG; Penning TM; Blair IA
Chem Res Toxicol; 2011 Jan; 24(1):89-98. PubMed ID: 21028851
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of aryl hydrocarbon receptor transactivation and DNA adduct formation by CYP1 isoform-selective metabolic deactivation of benzo[a]pyrene.
Endo K; Uno S; Seki T; Ariga T; Kusumi Y; Mitsumata M; Yamada S; Makishima M
Toxicol Appl Pharmacol; 2008 Jul; 230(2):135-43. PubMed ID: 18372000
[TBL] [Abstract][Full Text] [Related]
10. Effect of low-level short-term o-xylene inhalation of benzo[a]pyrene (BaP) metabolism and BaP-DNA adduct formation in rat liver and lung microsomes.
Park SH; Schatz RA
J Toxicol Environ Health A; 1999 Nov; 58(5):299-312. PubMed ID: 10598955
[TBL] [Abstract][Full Text] [Related]
11. Inhibition in vivo of the formation of adducts between metabolites of benzo(a)pyrene and DNA by aryl hydrocarbon hydroxylase inducers.
Wilson AG; Kung HC; Boroujerd M; Anderson MW
Cancer Res; 1981 Sep; 41(9 Pt 1):3453-60. PubMed ID: 6266656
[TBL] [Abstract][Full Text] [Related]
12. Dioxin suppresses benzo[a]pyrene-induced mutations and DNA adduct formation through cytochrome P450 1A1 induction and (±)-anti-benzo[a]pyrene-7,8-diol-9,10-epoxide inactivation in human hepatoma cells.
Shiizaki K; Kawanishi M; Yagi T
Mutat Res; 2013 Jan; 750(1-2):77-85. PubMed ID: 23036853
[TBL] [Abstract][Full Text] [Related]
13. Dose-dependent benzo(a)pyrene [B(a)P]-DNA adduct levels and persistence in F-344 rats following subchronic dietary exposure to B(a)P.
Ramesh A; Knuckles ME
Cancer Lett; 2006 Aug; 240(2):268-78. PubMed ID: 16288829
[TBL] [Abstract][Full Text] [Related]
14. Potential application of benzo(a)pyrene-associated adducts (globin or lipid) as blood biomarkers for target organ exposure and human risk assessment.
Kwack SJ; Kim DY; Kim YJ; Roh TH; Choi SM; Lim DS; Shin HS; Kim HS; Lee BM
J Toxicol Environ Health A; 2014; 77(22-24):1491-501. PubMed ID: 25343297
[TBL] [Abstract][Full Text] [Related]
15. Effects of solvent on DNA adduct formation in skin and lung of CD1 mice exposed cutaneously to benzo(a)pyrene.
Booth ED; Loose RW; Watson WP
Arch Toxicol; 1999 Aug; 73(6):316-22. PubMed ID: 10447559
[TBL] [Abstract][Full Text] [Related]
16. Time- and concentration-dependent induction of CYP1A1 and CYP1A2 in precision-cut rat liver slices incubated in dynamic organ culture in the presence of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Drahushuk AT; McGarrigle BP; Slezak BP; Stegeman JJ; Olson JR
Toxicol Appl Pharmacol; 1999 Mar; 155(2):127-38. PubMed ID: 10053167
[TBL] [Abstract][Full Text] [Related]
17. In vivo and in vitro inhibition of CYP1A-dependent activity in Fundulus heteroclitus by the polynuclear aromatic hydrocarbon fluoranthene.
Willett KL; Wassenberg D; Lienesch L; Reichert W; Di Giulio RT
Toxicol Appl Pharmacol; 2001 Dec; 177(3):264-71. PubMed ID: 11749126
[TBL] [Abstract][Full Text] [Related]
18. Induction of CYP1A1 and CYP1B1 in liver and lung by benzo(a)pyrene and 7,12-d imethylbenz(a)anthracene do not affect distribution of polycyclic hydrocarbons to target tissue: role of AhR and CYP1B1 in bone marrow cytotoxicity.
Galván N; Teske DE; Zhou G; Moorthy B; MacWilliams PS; Czuprynski CJ; Jefcoate CR
Toxicol Appl Pharmacol; 2005 Feb; 202(3):244-57. PubMed ID: 15667830
[TBL] [Abstract][Full Text] [Related]
19. Comparative in vitro and in vivo benzo[a]pyrene-DNA adduct formation and its relationship to CYP1A activity in two species of ictalurid catfish.
Ploch SA; King LC; Kohan MJ; Di Giulio RT
Toxicol Appl Pharmacol; 1998 Mar; 149(1):90-8. PubMed ID: 9512731
[TBL] [Abstract][Full Text] [Related]
20. The relationship between DNA adduct formation by benzo[a]pyrene and expression of its activation enzyme cytochrome P450 1A1 in rat.
Hodek P; Koblihová J; Kizek R; Frei E; Arlt VM; Stiborová M
Environ Toxicol Pharmacol; 2013 Nov; 36(3):989-96. PubMed ID: 24095716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
